Skip navigation
HKU Login
Guest Login
Home
Publications
Researchers
Staff
Research Postgraduates
Organizations
Grants
Datasets
Deposit Data
HKUL Research Data Management
Theses
Patents
Community Service
Browsing "Department of Clinical Oncology" by Author meng, y
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
中
or enter first few letters:
Showing results 2 to 12 of 12
< previous
Title
Author(s)
Issue Date
Views
DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis
Journal:
Clinical Oncology
Yiu, WS
Chu, TSM
Meng, Y
Kong, FS
24-Mar-2024
Dosimetric and Toxicity Benefits of Adaptive IMRT in Patients with Stage III Non-Small Cell Lung Cancer
Proceeding/Conference:
Journal of Thoracic Oncology
Meng, Y
Hou, L
Gu, P
Wang, W
Shen, Y
Zhou, S
Kong, FP
Yang, H
2019
10
Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer
Journal:
International Immunopharmacology
Lan, Y
Pi, W
Zhou, Z
Meng, Y
DanMei
Xu, Y
Xia, X
Wang, W
Yang, H
Kong, FM
1-Sep-2023
EGFR-TKIs May Sensitize Radiation Lung Damage in Stereotactic Body Radiotherapy Based on Intensity Analyzing
Proceeding/Conference:
Journal of Thoracic Oncology
Tang, X
Shen, Y
Meng, Y
Hou, L
Zhou, C
Yu, C
Wang, W
Yang, H
Kong, FP
2019
10
Function of Antisense LncRNA RP11-539E17.5 and FAM83A-AS1 Up-Regulating FAM83A in Lung Adenocarcinoma Tumorigenesis and Development
Proceeding/Conference:
Journal of Thoracic Oncology
Wang, X
Wang, W
Meng, Y
Zhou, S
Kong, FP
Yang, H
2019
14
Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
Proceeding/Conference:
Journal of Thoracic Oncology
Shen, Y
Meng, Y
Tang, X
Gu, P
Yu, C
Wang, W
Kong, FP
Yang, H
2019
11
Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
Proceeding/Conference:
Journal of Thoracic Oncology
Shen, Y
Meng, Y
Tang, X
Gu, P
Yu, C
Wang, W
Kong, FP
Yang, H
2019
11
PHLPP1 Expression Through AKT and ERK Dual Signaling Pathways May Slow Down the Resistance to TKI in EGFR-Mutated Lung Adenocarcinoma
Proceeding/Conference:
Journal of Thoracic Oncology
Wang, W
Lv, D
Meng, Y
Ye, M
Zhou, S
Kong, FP
Yang, H
2019
20
Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
Journal:
Annals of Palliative Medicine
Tang, X
Shen, Y
Meng, Y
Hou, L
Zhou, C
Yu, C
Jia, H
Wang, W
Ren, G
Cai, J
Li, XA
Yang, H
Kong, FP
2021
15
Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy
Proceeding/Conference:
Journal of Thoracic Oncology
Yang, H
Wang, W
Lv, D
Meng, Y
Zhou, S
Wu, X
Kong, FP
2019
27
Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC
Proceeding/Conference:
Journal of Thoracic Oncology
Lv, D
Xu, H
Meng, Y
Wang, W
Wu, X
Kong, FP
Yang, H
2019
26